Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2004 1
2005 1
2006 2
2007 3
2008 1
2009 1
2011 2
2012 5
2013 3
2014 1
2015 2
2016 2
2017 3
2018 1
2019 3
2020 5
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

32 results
Results by year
Filters applied: . Clear all
Page 1
Anastrozole versus tamoxifen for the prevention of locoregional and contralateral breast cancer in postmenopausal women with locally excised ductal carcinoma in situ (IBIS-II DCIS): a double-blind, randomised controlled trial.
Forbes JF, Sestak I, Howell A, Bonanni B, Bundred N, Levy C, von Minckwitz G, Eiermann W, Neven P, Stierer M, Holcombe C, Coleman RE, Jones L, Ellis I, Cuzick J; IBIS-II investigators. Forbes JF, et al. Lancet. 2016 Feb 27;387(10021):866-73. doi: 10.1016/S0140-6736(15)01129-0. Epub 2015 Dec 11. Lancet. 2016. PMID: 26686313 Free PMC article. Clinical Trial.
Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trial.
Cuzick J, Sestak I, Forbes JF, Dowsett M, Knox J, Cawthorn S, Saunders C, Roche N, Mansel RE, von Minckwitz G, Bonanni B, Palva T, Howell A; IBIS-II investigators. Cuzick J, et al. Lancet. 2014 Mar 22;383(9922):1041-8. doi: 10.1016/S0140-6736(13)62292-8. Epub 2013 Dec 12. Lancet. 2014. PMID: 24333009 Free article. Clinical Trial.
Cytoreductive Surgery for Heavily Pre-Treated, Platinum-Resistant Epithelial Ovarian Carcinoma: A Two-Center Retrospective Experience.
Tuninetti V, Di Napoli M, Ghisoni E, Maggiorotto F, Robella M, Scotto G, Giannone G, Turinetto M, Siatis D, Ponzone R, Vaira M, De Simone M, Scaffa C, Pignata S, Greggi S, Di Maio M, Valabrega G. Tuninetti V, et al. Among authors: maggiorotto f. Cancers (Basel). 2020 Aug 10;12(8):2239. doi: 10.3390/cancers12082239. Cancers (Basel). 2020. PMID: 32785193 Free PMC article.
Reoperation rate after breast conserving surgery as quality indicator in breast cancer treatment: A reappraisal.
Tamburelli F, Maggiorotto F, MarchiĆ² C, Balmativola D, Magistris A, Kubatzki F, Sgandurra P, Di Virgilio MR, Regge D, Montemurro F, Gatti M, Sapino A, Ponzone R. Tamburelli F, et al. Among authors: maggiorotto f. Breast. 2020 Oct;53:181-188. doi: 10.1016/j.breast.2020.07.008. Epub 2020 Aug 13. Breast. 2020. PMID: 32841804 Free PMC article.
MiR-100 is a predictor of endocrine responsiveness and prognosis in patients with operable luminal breast cancer.
Petrelli A, Bellomo SE, Sarotto I, Kubatzki F, Sgandurra P, Maggiorotto F, Di Virgilio MR, Ponzone R, Geuna E, Galizia D, Nuzzo AM, Medico E, Miglio U, Berrino E, Venesio T, Ribisi S, Provero P, Sapino A, Giordano S, Montemurro F. Petrelli A, et al. Among authors: maggiorotto f. ESMO Open. 2020 Oct;5(5):e000937. doi: 10.1136/esmoopen-2020-000937. ESMO Open. 2020. PMID: 33122354 Free PMC article.
Validation of Androgen Receptor loss as a risk factor for the development of brain metastases from ovarian cancers.
Mittica G, Goia M, Gambino A, Scotto G, Fonte M, Senetta R, Aglietta M, Borella F, Sapino A, Katsaros D, Maggiorotto F, Ghisoni E, Giannone G, Tuninetti V, Genta S, Eusebi C, Momi M, Cassoni P, Valabrega G. Mittica G, et al. Among authors: maggiorotto f. J Ovarian Res. 2020 May 4;13(1):53. doi: 10.1186/s13048-020-00655-2. J Ovarian Res. 2020. PMID: 32366278 Free PMC article.
Vaginal oestrogen therapy after breast cancer: is it safe?
Ponzone R, Biglia N, Jacomuzzi ME, Maggiorotto F, Mariani L, Sismondi P. Ponzone R, et al. Among authors: maggiorotto f. Eur J Cancer. 2005 Nov;41(17):2673-81. doi: 10.1016/j.ejca.2005.07.015. Epub 2005 Oct 18. Eur J Cancer. 2005. PMID: 16239103 Review.
32 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page